Clinical features and prognostic analysis of posterior reversible encephalopathy syndrome in children. Issue 4 (20th April 2022)
- Record Type:
- Journal Article
- Title:
- Clinical features and prognostic analysis of posterior reversible encephalopathy syndrome in children. Issue 4 (20th April 2022)
- Main Title:
- Clinical features and prognostic analysis of posterior reversible encephalopathy syndrome in children
- Authors:
- Deng, Ting
Zhang, Xinyu
Peng, Xiaoling
Peng, Hailun
He, Ling
Hu, Yue - Abstract:
- Abstract: Background: We aimed to investigate the clinical features and prognosis of posterior reversible encephalopathy syndrome (PRES) in children. Methods: Clinical data of children with PRES diagnosed at the Children's Hospital of Chongqing Medical University from June 2015 to May 2019 were retrospectively analyzed. Results: The study enrolled 47 patients with a mean age at diagnosis of 8.79 ± 3.72 years (range, 2–15 years). PRES causes included renal disorder (29/47), hematological disease (13/47), and hypertension (5/47). PRES manifested as seizure (43/47), headache (28/47), visual impairment (18/47), dizziness (18/47), vomiting (18/47), and mental and behavioral abnormalities (17/47). Forty‐six children had hypertension (46/47) at PRES onset. Magnetic resonance imaging (MRI) mainly involved the parietal and occipital lobes (42/47), 38 cases were mild (38/47), seven were moderate (7/47), and two were severe (2/47). The clinical symptoms of 41 patients (41/47) were relieved within 1–2 weeks. Thirty‐seven children were followed up for 7–54 months (modified Rankin Scale). Twenty‐five children had favorable outcomes (25/37). Twelve children had adverse outcomes (12/37), including epilepsy, disorders of consciousness, visual impairment, and mental decline. Analysis of single factors revealed that severity on MRI, length of in‐hospital stay, and mental and behavioral abnormalities were related to adverse outcomes after PRES. Analysis of multiple factors revealed thatAbstract: Background: We aimed to investigate the clinical features and prognosis of posterior reversible encephalopathy syndrome (PRES) in children. Methods: Clinical data of children with PRES diagnosed at the Children's Hospital of Chongqing Medical University from June 2015 to May 2019 were retrospectively analyzed. Results: The study enrolled 47 patients with a mean age at diagnosis of 8.79 ± 3.72 years (range, 2–15 years). PRES causes included renal disorder (29/47), hematological disease (13/47), and hypertension (5/47). PRES manifested as seizure (43/47), headache (28/47), visual impairment (18/47), dizziness (18/47), vomiting (18/47), and mental and behavioral abnormalities (17/47). Forty‐six children had hypertension (46/47) at PRES onset. Magnetic resonance imaging (MRI) mainly involved the parietal and occipital lobes (42/47), 38 cases were mild (38/47), seven were moderate (7/47), and two were severe (2/47). The clinical symptoms of 41 patients (41/47) were relieved within 1–2 weeks. Thirty‐seven children were followed up for 7–54 months (modified Rankin Scale). Twenty‐five children had favorable outcomes (25/37). Twelve children had adverse outcomes (12/37), including epilepsy, disorders of consciousness, visual impairment, and mental decline. Analysis of single factors revealed that severity on MRI, length of in‐hospital stay, and mental and behavioral abnormalities were related to adverse outcomes after PRES. Analysis of multiple factors revealed that severity on MRI and length of in‐hospital stay were independent risk factors for PRES. Conclusion: Pediatric PRES is a clinical radiographic syndrome with multiple etiologies. Most patients have a good prognosis. Severity on MRI and length of in‐hospital stay are independent risk factors. Abstract : The study enrolled 47 patients with a mean age at diagnosis of 8.79±3.72 years. PRES is a clinical radiographic syndrome with multiple etiologies, which included renal disorder, hematological disease, and hypertension. PRES manifested as seizure, headache, visual impairment, dizziness, vomiting, and behavioral abnormalities. MRI mainly involved the parietal and occipital lobes. Most patients have a good prognosis. Severity on MRI and length of in‐hospital stay are independent risk factors. … (more)
- Is Part Of:
- International journal of developmental neuroscience. Volume 82:Issue 4(2022)
- Journal:
- International journal of developmental neuroscience
- Issue:
- Volume 82:Issue 4(2022)
- Issue Display:
- Volume 82, Issue 4 (2022)
- Year:
- 2022
- Volume:
- 82
- Issue:
- 4
- Issue Sort Value:
- 2022-0082-0004-0000
- Page Start:
- 349
- Page End:
- 360
- Publication Date:
- 2022-04-20
- Subjects:
- children -- clinical feature -- posterior reversible encephalopathy syndrome -- prognosis
Developmental neurobiology -- Periodicals
Neurology -- Periodicals
Neurologie du développement -- Périodiques
Developmental neurobiology
Periodicals
612.8 - Journal URLs:
- https://onlinelibrary.wiley.com/journal/1873474x ↗
http://www.sciencedirect.com/science/journal/07365748 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1002/jdn.10184 ↗
- Languages:
- English
- ISSNs:
- 0736-5748
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.185100
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21779.xml